Metabolic syndrome (MetS) is currently recognized as a worldwide health problem, 1,2 and the substantial increase in fructose intake in human diet, especially as high-fructose corn syrup, has been considered a potential factor predisposing humans to MetS. 3,4 MetS is a cluster of different risk factors, such as increase in visceral fat deposition, glucose intolerance, dyslipidemia, and hypertension, which increases the risk of development of cardiovascular and renal diseases and type II diabetes mellitus. 2,5 Recent studies in rodents have shown that the renin-angiotensin system, through the inappropriate overactivity of angiotensin (Ang) II on Ang II type 1 (AT 1 ) receptor especially in the circulation and in the white adipose tissue, plays a pivotal role on the pathogenesis of MetS. [6][7][8] Peripheral blockade of Ang II synthesis or its action on AT 1 receptor attenuates metabolic disorders in obese rodents. [6][7][8] In contrast, the other functional arm of renin-angiotensin system, represented by the actions of Ang-(1-7) on Mas receptor, has been recognized widely as a counter-regulatory axis of Ang II/AT 1 receptor actions.Recent studies have shown that chronic increases in peripheral Ang-(1-7)/Mas receptor activity play a protective role in the regulation of cardiovascular and energy metabolism. Transgenic rats with increased Ang-(1-7) levels in the circulation [TGR(A1-7)3292] are protected against cardiac dysfunction, fibrosis, and hypertension when subjected to deoxycorticosterone (DOCA) acetate-salt model 9 and have enhanced resting glucose and lipid metabolism. 10 Accordingly, Giani et al 11,12 showed that chronic subcutaneous infusion of Ang-(1-7) improved insulin resistance, hypertension, and cardiac remodeling in fructose-fed rats. However, genetic deletion of Mas receptor alters glucose and lipid metabolism and the neural control of blood pressure, inducing a state of MetS. [13][14][15] Taken together, these data provide a clear evidence of a protective role of peripheral Ang-(1-7)/Mas receptor axis in the regulation of cardiovascular system and energy metabolism.Our group showed recently that chronic increase in Ang-(1-7) levels in the brain attenuates DOCA-salt hypertension, and that this effect is related to a dramatic beneficial role Abstract-We evaluated effects of chronic intracerebroventricular infusion of angiotensin (Ang)-(1-7) on cardiovascular and metabolic parameters in fructose-fed (FF) rats. After 6 weeks of fructose intake (10% in drinking water), SpragueDawley rats were subjected to intracerebroventricular infusion of Ang-(1-7) (200 ng/h; FF+A7 group) or 0.9% sterile saline (FF group) for 4 weeks with continued access to fructose. Compared with control rats, FF rats had increased mean arterial pressure and cardiac sympathetic tone with impaired baroreflex sensitivity. FF rats also presented increased circulating triglycerides, leptin, insulin, and glucose with impaired glucose tolerance. Furthermore, relative weights of liver and retroperitoneal adipose tissue were increased...